CBMG - Cellular Biomedicine Group Stock Trading

Cellular Biomedicine Group Inc.(NASDAQ: CBMG) stock trading, description, contact, officers and directors.

About Cellular Biomedicine Group Inc.

Cellular Biomedicine Group, Inc. CBMG is a biomedicine firm engaged in the development of new treatments for cancerous and degenerative diseases utilizing proprietary cell technologies, which include, without limitation, i haMPC human adipose derived mesenchymal progenitor cells for treatment of joint disease, ii huMPC human umbilical cord derived mesenchymal progenitor cells , iii TC DC tumor cell specific dendritic cells for treatment of a broad range of cancers and iv MNP human embryo derived motor neuron precursor cells and NP human embryo derived neuronal precursor cells for treatment of central nervous system diseases.

Stock Information

Cellular Biomedicine Group Inc. Company Name:

CBMG Stock Symbol:

NASDAQ Market:

CBMG CBMG Quote CBMG Short CBMG News CBMG Articles CBMG Message Board

Get CBMG Alerts

News, Short Squeeze, Breakout and More Instantly...

CBMG - Cellular Biomedicine Group, Inc. Announces Completion of Merger

Cellular Biomedicine Group, Inc. Announces Completion of Merger PR Newswire ROCKVILLE, Md. and SHANGHAI , Feb. 19, 2021 /PRNewswire/ -- Cellular Biomedicine Group, Inc. (NASDAQ: CBMG) ("CBMG" or the "Company") today announced the completion of the merger (th...
CBMG - Cellular Biomedicine Group, Inc. Stockholders Approve Merger

Cellular Biomedicine Group, Inc. Stockholders Approve Merger PR Newswire ROCKVILLE, Md. and SHANGHAI , Feb. 8, 2021 /PRNewswire/ -- Cellular Biomedicine Group, Inc. (NASDAQ: CBMG) ("CBMG" or the "Company") announced that, at the Company's special meeting...
CBMG - Leading Proxy Advisory Firms Glass Lewis and ISS Recommend Cellular Biomedicine Group Stockholders Vote FOR Proposed Merger

Leading Proxy Advisory Firms Glass Lewis and ISS Recommend Cellular Biomedicine Group Stockholders Vote FOR Proposed Merger PR Newswire ROCKVILLE, Md. and SHANGHAI , Jan. 28, 2021 /PRNewswire/ -- Cellular Biomedicine Group, Inc. (Nasdaq: CBMG) ("Company,...